| Synthesis, spectroscopic characterization, X-ray powder structure analysis, DFT study and in vitro anticancer activity of N-(2-methoxyphenyl)-3-methoxysalicylaldimine B Chattopadhyay, S Basu, P Chakraborty, SK Choudhuri, AK Mukherjee, ... Journal of Molecular Structure 932 (1-3), 90-96, 2009 | 69 | 2009 |
| Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate A Ganguly, S Basu, P Chakraborty, S Chatterjee, A Sarkar, M Chatterjee, ... PLoS One 5 (6), e11253, 2010 | 51 | 2010 |
| Use of BRET to study protein–protein interactions in vitro and in vivo S Dimri, S Basu, A De The Nuclear Receptor Superfamily: Methods and Protocols, 57-78, 2016 | 41 | 2016 |
| Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to … KB Lokhande, S Ballav, RS Yadav, KV Swamy, S Basu Journal of Biomolecular Structure and Dynamics 40 (3), 971-981, 2022 | 38 | 2022 |
| Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis A Ganguly, S Basu, K Banerjee, P Chakraborty, A Sarkar, M Chatterjee, ... Molecular BioSystems 7 (5), 1701-1712, 2011 | 35 | 2011 |
| Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff’s base to overcome MDR in cancer S Basu, A Ganguly, P Chakraborty, R Sen, K Banerjee, M Chatterjee, ... Biochimie 94 (1), 166-183, 2012 | 25 | 2012 |
| Drug repurposing—an emerging strategy in cancer therapeutics JA Khadija Shahab Turabi, Ankita Deshmukh, Sayan Paul, Dayanand Swami ... Naunyn Schmiedebergs Arch Pharmacol, 2022 | 24* | 2022 |
| Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule … KB Lokhande, S Ballav, N Thosar, KV Swamy, S Basu Journal of Molecular Modeling 26, 1-12, 2020 | 23 | 2020 |
| Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate K Banerjee, S Basu, S Das, A Sinha, MK Biswas, SK Choudhuri Free radical research 50 (4), 426-446, 2016 | 21 | 2016 |
| PPAR-γ partial agonists in disease-fate decision with special reference to cancer S Ballav, B Biswas, VK Sahu, A Ranjan, S Basu Cells 11 (20), 3215, 2022 | 20 | 2022 |
| QSAR modelling of pancreatic β-cell KATP channel openers R/S-3, 4-dihydro-2, 2-dimethyl-6-halo-4-(substituted phenylaminocarbonylamino)-2H-1-benzopyrans using MLR–FA techniques SM Alam, S Samanta, AK Halder, S Basu, T Jha European Journal of Medicinal Chemistry 44 (1), 359-364, 2009 | 19 | 2009 |
| QSAR for analogs of 1, 5-N, N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides as antitumor agents P Panda, S Samanta, M Alam Sk, S Basu, T Jha | 19 | 2007 |
| Detection and characterization of a glutathione conjugate of a novel copper complex S Basu, S Majumder, S Chatterjee, A Ganguly, T Efferth, SK Choudhuri in vivo 23 (3), 401-408, 2009 | 17 | 2009 |
| QSAR study on some orally active uracil derivatives as human gonadotropin–releasing–hormone receptor antagonists T Jha, S Samanta, S Basu, AK Halder, N Adhikari, MK Maiti Internet Electron J Mol Des 7 (11), 234-50, 2008 | 17 | 2008 |
| Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo A Ganguly, P Chakraborty, K Banerjee, S Chatterjee, S Basu, A Sarkar, ... Biometals 25, 149-163, 2012 | 13 | 2012 |
| Chemoimmunotherapeutic approach to prolonged survival time in combination with immunization and glutamic acid derivatives with antitumor activity in tumor-bearing mice S Samanta, SKM Alam, S Basu, T Maji, DK Roy, T Jha Biological and Pharmaceutical Bulletin 30 (12), 2334-2339, 2007 | 12 | 2007 |
| Structural finding of R/S-3, 4-dihydro-2, 2-dimethyl-6-halo-4-(substituted phenylaminocarbonylamino)-2 H-1-benzopyrans as selective pancreatic β-cells KATP-pβ channel openers SM Alam, S Samanta, AK Halder, S Basu, T Jha Canadian Journal of Chemistry 85 (12), 1053-1063, 2007 | 10 | 2007 |
| Designing Novel Quercetin Derivatives as Matrix Metalloproteinase-9 Inhibitors in Colon Carcinoma: An: In vitro: and: In silico: Approach S Ballav, KB Lokhande, I Dabhi, S Inje, A Ranjan, KV Swamy, S Basu Journal of Dental Research and Review 7 (Suppl 1), S30-S35, 2020 | 9 | 2020 |
| Two-Dimensional and Three-Dimensional Cell Culture and Their Applications SB Sangeeta Ballav, Ankita J Deshmukh, Shafina Siddiqui, Jyotirmoi Aich Intechopen, 2021 | 8* | 2021 |
| Image processing: An early detection tool for Alzheimer’s disease S Ballav, B Biswas, S Dey, VK Sahu, S Basu Smart Diagnostics for Neurodegenerative Disorders, 99-136, 2024 | 6 | 2024 |
Sangeeta BallavCenter for Innovation in Molecular & Pharmaceutical Sciences,Dr. Reddy's Institute of Life Sciences在 drils.org 的电子邮件经过验证
